Dimethylformamide

Dimethylformamide

SCHEMBL7714545

CCOC(=O)N1c2ccccc2C=CC1OCC.CCOC(=O)N1c2ccccc2C=CC1OCC.CN(C)C=O

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.84
LMNA P02545 2/20 0.84
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 4/20 0.39
MAPK1 P28482 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
P2RX4 Q99571 6/20 0.39
P2RX1 P51575 3/20 0.39
P2RX3 P56373 3/20 0.39
P2RX7 Q99572 2/20 0.39
PTBP1 P26599 1/20 0.39
BCHE P06276 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367474 0.92 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL29367804 0.92 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL338 0.92 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL23705539 0.92 SMN1; SMN2 (1.00) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
Carbimide SCHEMBL10800076 0.87 SMN1; SMN2 (0.90) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
1,2-Dichloroethane SCHEMBL28697158 0.87 SMN1; SMN2 (0.90) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL8063974 0.85 SMN1; SMN2 (0.82) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL8608444 0.85 SMN1; SMN2 (0.86) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL8608446 0.83 SMN1; SMN2 (0.82) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL9188247 0.83 SMN1; SMN2 (0.82) SMN1; SMN2LMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1257296-A2 CASPASE ACTIVATED PRODRUGS THERAPY GENENTECH, INC. (US) 2002-11-20 EP disclosed
WO-2001062300-A2 CASPASE ACTIVATED PRODRUGS THERAPY GENENTECH, INC. (US) 2001-08-30 WO disclosed